22 related articles for article (PubMed ID: 25820020)
1. Dosage and time of use of glucocorticoids in rheumatoid arthritis.
Abud-Mendoza C; Herrera vanOostdam DA
Reumatol Clin (Engl Ed); 2023 Dec; 19(10):596-597. PubMed ID: 38000934
[No Abstract] [Full Text] [Related]
2. Polymorphisms of MMP-1 and MMP-3 and susceptibility to rheumatoid arthritis. A meta-analysis.
Zhang C; Chen L; Gu Y
Z Rheumatol; 2015 Apr; 74(3):258-62. PubMed ID: 25854159
[TBL] [Abstract][Full Text] [Related]
3. Outcome predictors of intra-articular glucocorticoid treatment for knee synovitis in patients with rheumatoid arthritis - a prospective cohort study.
Weitoft T; Rönnelid J; Knight A; Lysholm J; Saxne T; Larsson A
Arthritis Res Ther; 2014 Jun; 16(3):R129. PubMed ID: 24950951
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the appearance of gelatinases in the synovial fluid of patients with rheumatoid arthritis and polymorphonuclear elastase, stromelysin-1, and the tissue inhibitor of metalloproteinase-1.
Watanabe Y; Shimamori Y; Fujii N; Yamaguchi R; Fujimoto Y; Matsuno H
Clin Exp Rheumatol; 1997; 15(3):255-61. PubMed ID: 9177919
[TBL] [Abstract][Full Text] [Related]
5. Sulphydryl groups in the synovial fluid in cases of rheumatoid arthritis, reactive synovitis of local origin and in post-mortem synovial fluid.
Hrncír Z; Tichý M; Salavec M; Vavrina J
Rev Czech Med; 1974; 20(1):34-8. PubMed ID: 4815840
[No Abstract] [Full Text] [Related]
6. Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assay.
Beekman B; van El B; Drijfhout JW; Ronday HK; TeKoppele JM
FEBS Lett; 1997 Dec; 418(3):305-9. PubMed ID: 9428733
[TBL] [Abstract][Full Text] [Related]
7. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis.
Ishiguro N; Ito T; Obata K; Fujimoto N; Iwata H
J Rheumatol; 1996 Sep; 23(9):1599-604. PubMed ID: 8877931
[TBL] [Abstract][Full Text] [Related]
8. The role of interleukin 1 in the pathogenesis of rheumatoid arthritis.
Miossec P
Clin Exp Rheumatol; 1987; 5(4):305-8. PubMed ID: 3326690
[No Abstract] [Full Text] [Related]
9. The use of glucocorticoids in early rheumatoid arthritis.
Verschueren P; Westhovens R
Rheumatology (Oxford); 2018 Aug; 57(8):1316-1317. PubMed ID: 28968687
[No Abstract] [Full Text] [Related]
10. Corticosteroids--a case of mistaken identity?
Goulding NJ
Br J Rheumatol; 1998 May; 37(5):477-80. PubMed ID: 9651071
[No Abstract] [Full Text] [Related]
11. No increase in synovial fluid level of matrix metalloproteinase-3 by systemic administration of glucocorticoids in rheumatoid arthritis.
Kamata Y; Minota S
Eur J Intern Med; 2015 Jun; 26(5):371-2. PubMed ID: 25820020
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
